THE COST-EFFECTIVENESS AND COST-UTILITY OF PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA IN GUATEMALA

被引：1
|
作者：
Obando, C. A. [1 ]
Gonzalez, L. [2 ]
Muschett, D. [1 ]
机构：
[1] Janssen, Panama City, Panama
[2] Janssen, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2089
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE FOR THE TREATMENT OF SCHIZOPHRENIA IN MEXICO
    Reyes-Lopez, A.
    Querol, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A561 - A561
  • [2] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE FOR THE TREATMENT OF SCHIZOPHRENIA IN GERMANY
    Zeidler, J.
    Mahlich, J. C.
    Greiner, W.
    Heres, S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A547 - A547
  • [3] Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
    Luo, Rui
    Lu, He
    Li, Hengfen
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany
    Zeidler J.
    Mahlich J.
    Greiner W.
    Heres S.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (5) : 509 - 521
  • [5] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS OTHER ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA IN FRANCE
    Doutriaux, A.
    Cognet, M.
    Druais, S.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A459 - A459
  • [6] Cost-effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France
    Doutriaux, A.
    Druais, S.
    Cognet, M.
    Lancon, C.
    Samalin, L.
    Levy, P.
    Godet, A.
    Guillon, P.
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S11 - S12
  • [7] THE COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE COMPARED TO OLANZAPINE PAMOATE IN THE TREATMENT OF SCHIZOPHRENIA IN SWEDEN
    Pudas, H.
    Hemels, M.
    Mehnert, A.
    Druais, S.
    Martin, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A560 - A561
  • [8] A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
    Abdall-Razak, Ali
    Macaulay, Alex
    Tiefenbach, Jakov
    Borges, Karen
    Mathema, Sina
    Zuberi, Sameer
    [J]. HELIYON, 2019, 5 (09)
  • [9] Erratum to: Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany
    Jan Zeidler
    Jörg Mahlich
    Wolfgang Greiner
    Stephan Heres
    [J]. Applied Health Economics and Health Policy, 2013, 11 (6) : 689 - 689
  • [10] A COST-EFFECTIVENESS ANALYSIS OF PALIPERIDONE PALMITATE VERSUS OLANZAPINE PAMOATE IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Einarson, T. R.
    Vicente, C.
    Zilbershtein, R.
    Piwko, C.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A292 - A293
12345